-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Cellular Therapy for Lymphoma (ticketed session for in-person participants)

Program: How I Treat: Bringing Science to Clinical Dilemmas
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Aqua Salon D (Hilton San Diego Bayfront)
Speaker:
Loretta J. Nastoupil, MD, MD Anderson Cancer Center
Disclosures:
Nastoupil: Gilead Sciences/Kite Pharma: Honoraria, Research Funding; AstraZeneca: Honoraria; Regeneron: Honoraria; Genentech, Inc., Genmab, Gilead/Kite, Janssen, Merck, Novartis, Takeda: Honoraria, Research Funding; Daiichi Sankyo: Honoraria, Research Funding; DeNovo: Honoraria; Caribou Biosciences: Honoraria, Research Funding; AbbVie: Honoraria; ADC Therapeutics: Honoraria; Bristol Myers Squibb/Celgene: Honoraria, Research Funding.
See more of: How I Treat: Bringing Science to Clinical Dilemmas
<< Previous Session | Next Session >>